“Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A Narrative Review” (2020) Indian Journal of Public Health Research & Development, 11(7), pp. 1063–1069. doi:10.37506/ijphrd.v11i7.10232.